Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Argan (AGX) Total Liabilities (2016 - 2026)

Argan (AGX) has disclosed Total Liabilities for 16 consecutive years, with $724.1 million as the latest value for Q1 2026.

  • Quarterly Total Liabilities rose 49.49% to $724.1 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $724.1 million through Jan 2026, up 49.49% year-over-year, with the annual reading at $724.1 million for FY2026, 49.49% up from the prior year.
  • Total Liabilities hit $724.1 million in Q1 2026 for Argan, up from $631.2 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $724.1 million in Q1 2026 to a low of $139.2 million in Q4 2022.
  • Historically, Total Liabilities has averaged $345.0 million across 5 years, with a median of $307.3 million in 2024.
  • Biggest five-year swings in Total Liabilities: plummeted 53.11% in 2022 and later skyrocketed 100.35% in 2023.
  • Year by year, Total Liabilities stood at $139.2 million in 2022, then surged by 100.35% to $278.8 million in 2023, then surged by 57.87% to $440.2 million in 2024, then surged by 43.39% to $631.2 million in 2025, then grew by 14.72% to $724.1 million in 2026.
  • Business Quant data shows Total Liabilities for AGX at $724.1 million in Q1 2026, $631.2 million in Q4 2025, and $489.5 million in Q3 2025.